Specifica, an IQVIA business
Zachary Cruz, PhD, is a Scientist II at Specifica, a Q² Solutions Company, where responsibilities primarily involve the library team focusing on molecular cloning techniques to develop antibody libraries in E. coli, as well as producing monoclonal yeast displaying single-chain Fabs and employing FACs for display and binding analysis. Prior to this position, Zachary Cruz spent nearly a decade at the University of Utah, where experiences included roles as a Postdoctoral Researcher and Graduate Research Assistant in Michael Kay's Lab, working on synthesizing various peptides with D-amino acids. Earlier experiences include serving as a Lead Tutor at California State University San Marcos and participating as a RISE Scholar, gaining essential research experience. Educational qualifications include a PhD in Biochemistry from the University of Utah and a BS in Biochemistry from California State University San Marcos, complemented by an AA in General Studies: Science and Mathematics from Palomar College.
This person is not in any teams
Specifica, an IQVIA business
1 followers
Antibody Libraries are the sources from which therapeutic antibodies can be generated using phage or yeast display. Specifica’s Generation 3 platform generates drug like antibodies, with broad diversity, high affinities and few biophysical liabilities, directly from naïve libraries. In addition to in-house designs, Specifica also collaborates closely with partners to create custom libraries in which essential elements are optimized according to partner needs.